The estimated Net Worth of Barbara B Hill is at least $945 Thousand dollars as of 21 May 2024. Ms. Hill owns over 36,350 units of Integra Lifesciences Corp stock worth over $639,760 and over the last 11 years she sold IART stock worth over $0. In addition, she makes $305,059 as Independent Presiding Director at Integra Lifesciences Corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Hill IART stock SEC Form 4 insiders trading
Barbara has made over 4 trades of the Integra Lifesciences Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently she bought 36,350 units of IART stock worth $995,990 on 21 May 2024.
The largest trade she's ever made was buying 36,350 units of Integra Lifesciences Corp stock on 21 May 2024 worth over $995,990. On average, Barbara trades about 726 units every 32 days since 2013. As of 21 May 2024 she still owns at least 36,350 units of Integra Lifesciences Corp stock.
You can see the complete history of Ms. Hill stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Barbara Hill biography
Barbara B. Hill serves as Independent Presiding Director of the Company. Ms. Hill is currently an Operating Partner of NexPhase Capital, a private equity firm (formerly Moelis Capital Partners), where she focuses on healthcare related investments and providing strategic operating support for its healthcare portfolio companies since 2011. From March 2006 to September 2010, Ms. Hill served as Chief Executive Officer and a director of ValueOptions, Inc., a managed behavioral health company, and FHC Health Systems, Inc., its parent company. In addition, from 2002 to 2003, Ms. Hill served as President and a director of Express Scripts, Inc., a pharmacy benefits management company. In previous positions, Ms. Hill was responsible for operations nationally for Cigna HealthCare, and also served as the CEO of health plans owned by Prudential, Aetna and the Johns Hopkins Health System. She was active with the boards or committees of the Association of Health Insurance Plans and other health insurance industry groups. Ms. Hill serves as a board member as well as a member of the Compensation Committee of Owens & Minor Inc., a healthcare product distribution company. Ms. Hill also serves as a board member and a member of the Compensation Committee of Omega Healthcare Investors, Inc., a Maryland real estate investment trust. Until 2017, Ms. Hill also served as a board member of Revera Inc., a Canadian company operating seniors’ facilities throughout Canada, Great Britain, and the United States, and as a board member of St. Jude Medical Corporation, a medical device company. Ms. Hill received B.A and M.S. degrees from the Johns Hopkins University.
What is the salary of Barbara Hill?
As the Independent Presiding Director of Integra Lifesciences Corp, the total compensation of Barbara Hill at Integra Lifesciences Corp is $305,059. There are 10 executives at Integra Lifesciences Corp getting paid more, with Peter Arduini having the highest compensation of $7,859,420.
What's Barbara Hill's mailing address?
Barbara's mailing address filed with the SEC is 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY, MD, 21030.
Insiders trading at Integra Lifesciences Corp
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig, and George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
What does Integra Lifesciences Corp do?
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
What does Integra Lifesciences Corp's logo look like?
Complete history of Ms. Hill stock trades at Integra Lifesciences Corp, Omega Healthcare Investors, and Owens & Minor
Integra Lifesciences Corp executives and stock owners
Integra Lifesciences Corp executives and other stock owners filed with the SEC include:
-
Peter Arduini,
President, Chief Executive Officer, Director -
Glenn Coleman,
Chief Operating Officer, Executive Vice President -
Carrie Anderson,
Chief Financial Officer, Executive Vice President -
Eric Schwartz,
Executive Vice President, Chief Legal Officer, Secretary -
Robert Davis,
Executive Vice President, President - Orthopedics and Tissue Technologies -
Glenn G. Coleman,
Exec. VP & COO -
Carrie L. Anderson,
Exec. VP, CFO & Treasurer -
Robert T. Davis Jr.,
Exec. VP and Pres of Orthopedics & Tissue Technologies -
Stuart Essig,
Independent Chairman of the Board -
Rhonda Ballintyn,
Independent Director -
Barbara Hill,
Independent Presiding Director -
Christian Schade,
Independent Director -
Donald Morel,
Independent Director -
Lloyd Howell,
Independent Director -
Keith Bradley,
Independent Director -
Raymond Murphy,
Independent Director -
Michael Beaulieu,
IR Contact Officer -
Jeffrey Mosebrook,
Senior Vice President, Principal Accounting Officer -
Michael McBreen,
Executive Vice President and President - Codman Specialty Surgical -
Lisa Evoli,
Executive Vice President, Chief Human Resources Officer -
Eric Ian Schwartz,
Exec. VP, Chief Legal Officer & Sec. -
William Compton,
Chief Information Officer & Sr. VP -
Dr. Kenneth E. Burhop Ph.D.,
Corp. VP & Chief Scientific Officer -
Jeffrey Mosebrook,
Sr. VP, Principal Accounting Officer & Corp. Controller -
Dr. Richard E. Caruso,
Founder and Chairman Emeritus -
Jan De Witte,
Pres, CEO & Director -
James M Sullivan,
Director -
John Mooradian,
Corp VP, Global Ops & Supp Chn -
Judith Ogrady,
CorpVP,Global Reg.Affairs -
Kenneth Burhop,
CORPVP,CHIEFSCIENTIFIC OFFICER -
Mark A Augusti,
CVP,PRES-ORTHO & TISSUE TECH -
Richard D. Gorelick,
Corp VP, Gen Counsel & Sec -
Harvinder Singh,
EVP & PRESIDENT, INTERNATIONAL -
Chantal Veillon Berteloot,
EVP & CHRO -
Richard E Caruso,
10% owner -
Witte Jan De,
President & CEO -
Joseph Vinhais,
Corp VP,Quality&Transformation -
George Soros,
10% owner -
David B Holtz,
Sr. VP, Finance -
David C Auth,
Director -
Don R Nociolo,
Senior V.P., Operations -
Michael Piershbacher,
Senior VP, Research & Dev. -
Maureen B Bellantoni,
Exec V.P./CFO -
Neal Moszkowski,
Director -
Anne Vanlent,
Director -
Thomas J Jr Baltimore,
Director -
Daniel L. Reuvers,
CVP,PRES - CODMAN SPC SURGICAL -
Deborah A Leonetti,
Senior VP, Marketing -
Padma Thiruvengadam,
Corp VP, Chief HR Officer -
Robert D Paltridge,
Sr. VP, Global Sales -
Gerard S Carlozzi,
Exec. V.P., COO -
Brian Larkin,
Corp VP, Pres.Gbl Spine &Ortho -
John B Iii Henneman,
Exec. V.P., CAO, & Secretary -
Jerry E Corbin,
VP & Corporate Controller -
St Partnership, L.P. Tru,
10% owner -
Jeffrey A Graves,
Director -
Renee Wonlai Lo,
Director -
Lea Daniels Knight,
EVP & CHIEF FINANCIAL OFFICER